摘要
目的加强对新型抗肿瘤药物奥希替尼治疗后发生肺栓塞患者的药学监护,为临床安全用药提供参考。方法回顾临床药师参与1例肺腺癌患者接受奥希替尼治疗后出现肺栓塞的治疗过程,对治疗过程中出现的肺栓塞不良事件进行评估,并结合患者病情及个人意愿对抗凝药物的选择提供建议。结果临床药师全程参与药物治疗并实施药学监护与药学随访,患者肺栓塞情况控制良好,为患者继续抗肿瘤治疗提供了保障。结论临床药师通过优化治疗方案,提供药学监护,保障了患者用药安全有效。
OBJECTIVE To strengthen the pharmaceutical monitoring of patients with pulmonary embolism(PE)after the treatment of oxitinib,a new antineoplastic drug,so as to provide reference for clinical medication safety.METHODS A clinical pharmacist was participated in the treatment of a patient with adenocarcinoma of the lung who developed pulmonary embolism after receiving oxitinib.The adverse events of pulmonary embolism during the treatment were evaluated,the choice of anticoagulants was suggested according to the patients′condition and personal wishes.RESULTS The clinical pharmacists participated in the whole course of drug treatment and performed pharmaceutical care and pharmaceutical follow-up.The pulmonary embolism was well controlled,which provided guarantee for the patients to continue anti-tumor treatment.CONCLUSION Clinical pharmacists ensure the safety and effectiveness of drug use by optimizing therapeutic regimens and providing pharmaceutical care.
作者
杜瑞超
陈忠光
卢秀花
DU Rui-chao;CHEN Zhong-guang;LU Xiu-hua(Department of Clinical Pharmacy,Linyi Central Hospital,Linyi 276400,China)
出处
《海峡药学》
2023年第6期62-65,共4页
Strait Pharmaceutical Journal
基金
山东省医学会临床科研基金-齐鲁专项,项目编号:YXH-2022ZX02069
山东省中医药管理局面上项目,项目编号:M-2022107。
关键词
奥希替尼
肺栓塞
临床药师
Oxitinib
Pulmonary embolism
Clinical pharmacists
